{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:20:01Z","timestamp":1778822401347,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.aohep.2020.04.008","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T11:44:41Z","timestamp":1590493481000},"page":"530-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Propranolol for infantile hepatic hemangioendothelioma: Clinical evaluation of drug efficacy and safety using a single-center patient cohort"],"prefix":"10.1016","volume":"19","author":[{"given":"Ruicheng","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2020.04.008_bib0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00268-008-9882-4","article-title":"Clinical experience with infantile hepatic hemangioendothelioma","volume":"33","author":"Moon","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.aohep.2020.04.008_bib0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3345\/kjp.2011.54.6.260","article-title":"Clinical features of infantile hepatic hemangioendothelioma","volume":"54","author":"Kim","year":"2011","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.aohep.2020.04.008_bib0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2010.04.003","article-title":"Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis","volume":"157","author":"Mazereeuw-Hautier","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.aohep.2020.04.008_bib0120","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1432-2277.2010.01107.x","article-title":"Liver transplantation and vascular tumours","volume":"23","author":"Bonaccorsi-Riani","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.aohep.2020.04.008_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2018.08.012","article-title":"Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring","volume":"203","author":"Iacobas","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.aohep.2020.04.008_bib0130","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/MPG.0b013e31824e50b7","article-title":"Propranolol as a first-line treatment for diffuse infantile hepatic hemangioendothelioma","volume":"56","author":"Avagyan","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.aohep.2020.04.008_bib0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/MPH.0000000000001536","article-title":"Outcome of children treated for infantile hepatic hemangioendothelioma","volume":"42","author":"Emad","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.aohep.2020.04.008_bib0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/rg.243035046","article-title":"Congenital hepatic shunts","volume":"24","author":"Gallego","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.aohep.2020.04.008_bib0145","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.aohep.2020.04.008_bib0150","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nrd3531","article-title":"Rapamycin passes the torch: a new generation of mTOR inhibitors","volume":"10","author":"Benjamin","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.aohep.2020.04.008_bib0155","doi-asserted-by":"crossref","first-page":"e20153257","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.aohep.2020.04.008_bib0160","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Leaute-Labreze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2020.04.008_bib0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.lpm.2017.01.010","article-title":"Infantile hepatic hemangioendothelioma successfully treated by low dose of propranolol","volume":"46","author":"Maaloul","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.aohep.2020.04.008_bib0170","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1017\/S1047951118000987","article-title":"Cost-effectiveness of treating infantile haemangioma with propranolol in an outpatient setting","volume":"28","author":"Chaturvedi","year":"2018","journal-title":"Cardiol Young"},{"key":"10.1016\/j.aohep.2020.04.008_bib0175","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MPG.0b013e3182201a4e","article-title":"Successful first-line treatment with propranolol of multifocal infantile hepatic hemangioma with high-flow cardiac overload","volume":"53","author":"Sciveres","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.aohep.2020.04.008_bib0180","doi-asserted-by":"crossref","first-page":"e2344","DOI":"10.1097\/MD.0000000000002344","article-title":"Infantile hepatic hemangioendothelioma associated with congestive heart failure: two case reports with different outcomes","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.aohep.2020.04.008_bib0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5582\/ddt.2017.01025","article-title":"Beta blocker and steroid therapy in the treatment of infantile hepatic hemangioendothelioma","volume":"11","author":"Ozdemir","year":"2017","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.aohep.2020.04.008_bib0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/15569527.2011.554483","article-title":"Efficacy and safety of propranolol in the treatment of parotid hemangioma","volume":"30","author":"Morais","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.aohep.2020.04.008_bib0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hep.29028","article-title":"Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report","volume":"66","author":"Varrasso","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.04.008_bib0200","doi-asserted-by":"crossref","first-page":"e14078","DOI":"10.1097\/MD.0000000000014078","article-title":"Efficacy of infantile hepatic hemangioma with propranolol treatment: a case report","volume":"98","author":"Tsai","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:40:16Z","timestamp":1761648016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268120300478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1665268120300478"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2020.04.008","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propranolol for infantile hepatic hemangioendothelioma: Clinical evaluation of drug efficacy and safety using a single-center patient cohort","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2020.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}